Autocrine production and synergistic growth-promoting activity of interleukin-6 and oncostatin M in a new human myeloma cell line TU-1

Acta Haematologica

Volumn 107, Issue 1, 2002, Pages 23-28

  Koskela, Kari ^a,c,e   Pelliniemi, T T ^b   Pelliniemi, L J ^a   Remes, K ^a   Sodestrom K O ^a   Punnonen, K ^b   Kumar, R ^d   Ollikainen, H ^c   Pulkki, K ^b,c  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e TURKU CITY HOSPITAL   (Finland)

Author keywords

Cytokine; Interleukin 6; Myeloma cell line, human; Oncostatin M

Indexed keywords

GROWTH FACTOR; GROWTH PROMOTOR; INTERLEUKIN 6; ONCOSTATIN M;

ADULT; ARTICLE; BLOOD LEVEL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MYELOMA; MYELOMA CELL; PRIORITY JOURNAL;

AUTOCRINE COMMUNICATION; CELL DIVISION; DRUG SYNERGISM; GENES, IMMUNOGLOBULIN; GENES, P16; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE MYELOMA; ONCOSTATIN M; PEPTIDES; SEQUENCE DELETION; TUMOR CELLS, CULTURED;

EID: 0036288966     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046625     Document Type: Article

References (41)

1. Interleukin-6 in human multiple myeloma
2. Interleukin-6 family of cytokines and gp130
3. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias
4. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma
5. Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma
6. A growth regulator produced by differentiated histiocytic lymphoma cell
7. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6
8. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression
9. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop
10. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling
11. The IL-6 signal transducer, gp130: An oncostatin M receptor and affinity converter for the LIF receptor
12. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130
13. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130
14. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
15. gp130 in human myeloma/plasmacytoma
16. Lack of IL-1 secretion from human myeloma cells highly purified by immunomagnetic separation
17. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient
18. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
19. Flow cytometric DNA analysis and clinical correlations in multiple myeloma
20. Intermediate filaments and epithelial differentiation of male rat embryonic gonad
21. Development of a highly sensitive assay, based on the polymerase chain reaction, for rare B-lymphocyte clones in a polyclonal population
22. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells
23. EBER in situ hybridization: Sensitive detection of latent Epstein-Barr virus in individual cells
24. Human myeloma cell lines as a tool for studying the biology of multiple myeloma: A reappraisal 18 years after
25. In vitro growth of human multiple myeloma: Implications for biology and therapy
26. Establishment of a new human myeloma cell line (U-2030) and selection of a HAT-sensitive subline
27. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
28. The biology of interleukin-6
29. Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 for their growth
30. Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2)
31. The p53 proto-oncogene can act as a suppressor of transformation
32. Mutations of the p53 gene in human myeloma cell lines
33. Rare occurrence of p53 gene mutations in multiple myeloma
34. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
35. p53 gene mutations are rare in patients but common in patient-originating cell lines in multiple myeloma
36. A cell cycle regulator potentially involved in genesis of many tumor types
37. Loss of the cyclin-dependent kinase 4-inhibitor (p16;MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies
38. INK4C genes in multiple myeloma
39. Serum oncostatin M in multiple myeloma: Association with prognostic factors
40. Serum oncostatin M in multiple myeloma: Impact on disease severity and prognosis
41. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma